People who have previously run GLP-1 based compounds and noticed post-cycle skin changes, either laxity or reduced firmness compared to their target weight look, are strong candidates for adding GHK-Cu to their next Retatrutide cycle
Performance and volatility metrics Performance and volatility metrics (as of 6/30/2026) Morningstar ratings and rankings Morningstar ratings and rankings (as of 6/30/2026) Overall Large Value (Out of 1054 funds) Three Year 46th percentile (472 out of 1054) Five Year 40th percentile (369 out of 991) Ten Year 33rd percentile (253 out of 830) The Overall Morningstar Rating for a fund is derived from a weighted-average of the performance figures associated with its three-, five- and ten-year (if applicable) ratings
Hypothyroidism is often a cause of Vitamin B12 deficiency, arising from the reduced absorption of B12, poor utilisation of the liver, and general organ disfunction associated with hypothyroidism, and sometimes by dietary insufficiency of B12 (particularly in the case of a vegetarian diet)
The published research literature describes GHK-Cu as exerting effects through multiple coordinated mechanisms: stimulation of fibroblast proliferation and migration
Treatment Frequency Depending on the patient, some protocols involve a daily administration, administration of three to five doses weekly, or administration on a rotating schedule
